Covid-19 man­u­fac­tur­ing roundup: Brazil to man­u­fac­ture Vaxzevria at home; As­traZeneca ramp up in Spain gets the OK

Thanks to a tech­nol­o­gy trans­fer to a promi­nent Latin Amer­i­can sci­ence in­sti­tu­tion, Brazil is now able to man­u­fac­ture the As­traZeneca Covid-19 vac­cine do­mes­ti­cal­ly.

Fiocruz, a fed­er­al, pub­lic in­sti­tu­tion, will al­lo­cate all of the man­u­fac­tured dos­es of Vaxzevria to the Brazil­ian Min­istry of Health for pub­lic use. The news was first re­port­ed by Pink Sheet, and con­firmed by a pa­per ti­tled “Ef­fec­tive­ness of Vaxzevria and Coro­n­aVac vac­cines in Brazil,” from sci­en­tists in Brazil.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER